Vertaling van "scientific data needed for " (Nederlands → Frans) :

Richtlijnen van de EFSA (Europese Voedselauthoriteit) voor de evaluatie van aroma’s zijn te vinden op haar website (WEB, Engels). Daarenboven zijn er ook “explanatory notes for guidance giving explanatory examples of scientific data needed for the risk assessment established in the EFSA Guidance” (WEB, in het Engels).
Des guidelines de l'EFSA (Autorité européenne de Sécurité des aliments) destinées à l'évaluation des arômes se trouvent sur son site internet (WEB, en anglais), où l'on trouve également des " explanatory notes for guidance giving explanatory examples of scientific data needed for the risk assessment established in the EFSA Guidance" (WEB, en anglais).

To raise Belgium’s profile even further in the European context, regulatory and scientific expertise needs to carry on being developed, and the quality of the services delivered needs to be monitored and improved continuously.
To raise Belgium’s profile even further in the European context, regulatory and scientific expertise needs to carry on being developed, and the quality of the services delivered needs to be monitored and improved continuously.

Lecture: Quality of care assessment using GP's electronic patient records : do we need data from home visits ? (.Powerpoint) by Hans Vandenberghe, Scientific Institute of Public Health (IPH), unit of Epidemiology, Brussels (B)
Lecture: Quality of care assessment using GP's electronic patient records (.Powerpoint) : do we need data from home visits ? by Hans Vandenberghe, Scientific Institute of Public Health (IPH), unit of Epidemiology, Brussels (B)

Data from the “sentinel general practitioners” (Scientific Institute of Public Health). Sentinel general practitioners form a network of general practitioners who are responsible to the various communities and register medical data including, amongst other things, suicides and attempted suicides.
Les médecins vigies constituent un réseau de médecins généralistes, dépendant des différentes communautés, qui enregistrent des données médicales dont, entre autres, les suicides et tentatives de suicide.

Encouraging clinical trials and the inherent evaluation of applications for these trials, as well as the creation of a scientific subgroup for oncology, means that the FAMHP will need to have the necessary autonomy to attract the essential expertise for this relatively complex domain from the point of concept of innovative medicines.
Encouraging clinical trials and the inherent evaluation of applications for these trials, as well as the creation of a scientific subgroup for oncology, means that the FAMHP will need to have the necessary autonomy to attract the essential expertise for this relatively complex domain from the point of concept of innovative medicines.

The Resident Assessment Instrument (RAI) 444 is originally developed to Only for breast cancer and colon cancer, the US has higher survival rates assess the care needs of the elderly in institutions, and has later been than Belgium (data shown in documentation sheet in Supplement S1). To extended with instruments for different care settings and subgroups. In be able to distinguish the effect of early screening from the actual care, Belgium a national pilot project (the BelRAI) is ongoing, but is not yet implemented in all care settings: the assessment instruments for home care, relative survival rates should be compared across countries by stage, for long-term care facilities and acute care have already been adapted to information which is not yet available at international level. the Belgian situation (details in Appendix C).
Belgium a national pilot project (the BelRAI) is ongoing, but is not yet be able to distinguish the effect of early screening from the actual care, implemented in all care settings: the assessment instruments for home care, relative survival rates should be compared across countries by stage, for long-term care facilities and acute care have already been adapted to information which is not yet available at international level. the Belgian situation (details in Appendix C).

Lecture: From Patient Data to Information needs (.Powerpoint) by Loes Braun, Institute for Knowledge and Agent Technology, Universiteit Maastricht (NL)
Lecture: From Patient Data to Information Needs (.Powerpoint) by Loes Braun, Institute for Knowledge and Agent Technology, Universiteit Maastricht (NL)

mechanisms, individual private insurances reimburse several healthcare Macro-level data on the needs should be complemented with dataa that services.
transparency in ambulatory supplements as well as in private hospital illustrated that in Belgian hospitals nurses have, on average, to take care insurances (the percentage of people with private hospital insurance, and for more patients compared to other EU countries.

The data in this source need, of course, to agree with those that have been approved or determined by the competent authority for marketing authorisation – MA (FAMHP), price (FPS Economy) and reimbursement modalities (RIZIV-INAMI), respectively.
The data in this source need, of course, to agree with those that have been approved or determined by the competent authority for marketing authorisation – MA (FAMHP), price (FPS Economy) and reimbursement modalities (RIZIV-INAMI), respectively.

In this context the FAMHP supports provision of pharmacotherapeutic information to care providers and has concluded partnerships with independent organisations providing objective information about medicines (for instance the Belgian Centre for Pharmacotherapeutic Information – BCFI-CBIP and Project Farmaka, not-for-profit organisations). This process needs to take into consideration the expectations of healthcare professionals in terms of information content on the one hand, and the ease of access and consultation of the data on the other.
In this context the FAMHP supports provision of pharmacotherapeutic information to care providers and has concluded partnerships with independent organisations providing objective information about medicines (for instance the Belgian Centre for Pharmacotherapeutic Information – BCFI-CBIP and Project Farmaka, not-for-profit organisations). This process needs to take into consideration the expectations of healthcare professionals in terms of information content on the one hand, and the ease of access and consultation of the data on the other.